DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, supplying promising developments throughout different health-related and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, more trustworthy different for therapeutic use,